Lv75
4069 积分 2021-07-15 加入
Secondary malignancy of T-cell origin after CAR T-cell therapy: EMA’s conclusions from the evaluation of 38 suspected cases
2天前
已完结
Assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs: Are available data sufficient to inform risk assessment?
2天前
已完结
Dose level selection for Developmental and Reproductive Toxicology (DART) studies: Insights from the EUROTOX 2024 Satellite Workshop
2天前
已完结
A Roadmap guide on bioanalysis challenges and practical solutions for accurate quantification of oligonucleotide-based novel therapeutic modalities using LC-MS
2天前
已完结
Scientific and Regulatory Policy Committee Points to Consider*: Sample Selection, Assay Design, Data Generation and Interpretation, and Reporting Practices for Chromogenic Immunohistochemical (IHC) Assays in Nonclinical Drug Development
2天前
已完结
Beyond Eye Changes in Ocular Toxicity Studies: Practical Considerations for Sampling and Evaluation of Extraocular Visual Pathways, and Common Findings
2天前
已完结
An IQ Consortium Perspective on the FDA Guidance for Assessment of Pharmacokinetics in Participants With Impaired Renal Function
3天前
已完结
Pathology Findings and In-Life Correlates in the Nonclinical Development of Adeno-Associated Virus (AAV)-Based Retinal Gene Therapies
17天前
已完结
Neuropathological Findings in Nonclinical Species Following Administration of Adeno-Associated Virus (AAV)-Based Gene Therapy Vectors
17天前
已完结
Principles for Assessing Adversity in Toxicologic Clinical Pathology
17天前
已完结
皖公网安备34019202002308
